What is the FTC investigating regarding the Cencora-Covetrus deal?

The U.S. Federal Trade Commission is conducting a closer antitrust review of Cencora’s proposed $3.5 billion sale of MWI Animal Health to privately held Covetrus, sending information demands to customers and rivals of both companies to assess the deal’s impact on veterinary product availability and practice-management software used by clinics for patient records, prescriptions, and payments.

Why is Cencora selling MWI Animal Health to Covetrus?

Cencora announced in February that it would sell MWI Animal Health to Covetrus as part of a strategic shift to sharpen its focus on drug distribution and divest non-core businesses.

FTC Takes Closer Look at Cencora-Covetrus Animal Health Merger

Aug 4, 2026

The U.S. FTC investigates Cencora's $3.5 billion acquisition of Covetrus, requesting details on veterinary product availability and clinic software impacts. Cencora intends to sell the unit to focus on core drug distribution.

reuters

2026-08-04

FTC Takes Closer Look at Cencora-Covetrus Animal Health Merger

FTC Takes Closer Look at Cencora-Covetrus Animal Health Merger

FAQ